Guardant Health.
American biotechnology company
- Reports this week
- 1
- Active events
- 1
- Connections
- 70
What's happening
Active this week
Earlier this month
-
GRAIL and Guardant Health, both companies specializing in cancer detection blood tests, are trading on the Nasdaq stock exchange.Some support1 report
-
Scott Bessent's call for a rate cut fuels a risk-on environment for companies like agilon health.Some support5 reports1 development inside
-
EVANS welcomed Guardant Health as a sponsor for a coalition planning events across North America.Some support1 report
One to three months ago
-
Guardant Health is listed on the electronic stock exchange (Nasdaq) and is targeting reimbursement from federal programs (Medicare).Some support1 report
-
Insider Chris Freeman sold shares of Guardant Health during the reporting period, leading to an SEC filing on September 14, 2026.Some support1 report
-
Comparative market analysis of two healthcare companies, Amplifon and Guardant Health, began on September 1, 2026.Some support2 reports
-
David Gardner recommended Guardant Health stock multiple times on August 31, 2026.Some support1 report
-
Nvidia and Guardant Health are noted as dominant tech names in growth ETFs, driven by AI and cloud spending.Some support2 reports
-
Several companies, including Guardant Health and Myriad Genetics, are competing in the liquid biopsy market.Some support1 report1 development inside
-
Mizuho Securities lifted its price target and disclosed a transaction involving Guardant Health in an SEC filing.Some support1 report
-
Guardant Health reported results from Palo Alto on July 31, 2025. Shield MCD received Breakthrough Device Designation from the FDA and was included in NCCN colorectal cancer screening guidelines.Well supported4 reports3 developments inside
-
The company Guardant Health, which has a director, is based in Palo Alto.Some support1 report
-
Guardant Health shares are traded on Nasdaq, Mizuho raised its price target, and FDA approval spurred a positive market reaction.Well supported5 reports
-
Guardant Health CEO sold company shares in a disclosed transaction after filing disclosures with the SEC, trading on Nasdaq.Some support2 reports
Gone quiet
No new reports in 90+ days-
Royal Bank of Canada provided stock coverage for Guardant Health on July 2, 2026.Some support1 report
-
SPDR fund announced it holds shares of Molina Healthcare, BrightSpring Health Services, and Guardant Health.Some support3 reports
-
Agilent Technologies and Guardant Health are in the life sciences sector, and analyst coverage was initiated on Agilent's shares.Some support1 report
-
Guardant Health traded on the NASDAQ stock exchange on June 23, 2026.Some support1 report
-
Guardant Health expands access to its blood test in Wisconsin.Some support1 report
-
Director Ian T Clark sold shares in Guardant Health on June 21, 2025.Speculative1 report
-
Insider AmirAli Talasaz sold shares worth $5,087,630 at Guardant Health on July 3, 2025.Speculative1 report
-
Strategic partnership integrates Guardant Health's portfolio into the VieCure platform, with Michael Power as CEO of VieCure Inc.Some support1 report
-
Guardant Health announced on July 15, 2025, that its test was being used in the NCI's Vanguard Study, with data presented at ASCO in Chicago and FDA review initiated for IDE.Some support2 reports
-
Meaghan Smith serves as the media contact for Guardant Health.Some support1 report
-
Guardant Health and Zebra Technologies provide specialized industrial equipment amidst market volatility influenced by political events.Some support1 report
-
Guardant Health announced a partnership on July 30, 2025, aimed at raising awareness about Colorectal Cancer (CRC) screening.Some support1 report
-
Zacks Investment Research published stock analysis reports concerning Guardant Health on July 31, 2025.Some support1 report
-
Guardant Health used LinkedIn for company communication and had a representative participate in a conference held in Boston.Some support1 report
-
Guardant Health develops blood tests for cancer detection, and Compass operates as a residential real estate brokerage.Some support1 report
-
Guardant Health announced AmirAli Talasaz as Co-CEO, alongside reports of volume growth and gross margin turnaround.Some support3 reports
-
Rate cut speculation is noted to benefit growth sectors, including healthcare companies like Guardant Health.Some support2 reports1 development inside
-
Guardant Health is governed by Nasdaq Listing Rule 5635(c)(4) regarding stock grants.Some support1 report
-
Guardant Health develops blood tests for cancer detection, LGI Homes specializes in US home construction, and Maximus provides government services.Some support1 report
-
Guardant Health participated in a conference hosted by Morgan Stanley on August 27, 2025.Some support1 report
-
Guardant Health announced it will host its Investor Day in New York City on August 29, 2025.Some support1 report
-
Guardant Health and Natera face a lawsuit regarding disputes over cancer diagnostics and misleading advertising claims, presided over by Judge Edward Chen.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around Guardant Health this week
News at the entities that move Guardant Health most-
FDA StructuralFDA conducted widespread seizures of prohibited food items and products across Pune, Nashik, Mumbai, Konkan, and Nanded.Moves Guardant Health
-
American Cancer Society StructuralKai Trump posted a video with his mother, Vanessa Trump, while the American Cancer Society provided data on breast cancer rates.Moves Guardant Health
-
Mizuho Securities OperationalRoyal Bank of Canada adjusted its rating on Ball Corporation stock, while Mizuho Securities set a price objective, coinciding with Ball's SEC filings.Moves Guardant Health
-
Leerink partners TransactionalIntuitive Surgical received a Buy rating from Leerink partners, citing increased da Vinci placements and potential benefits from Trump-era tariffs.Moves Guardant Health
-
Nasdaq StructuralThe First Trust RBA American Industrial Renaissance ETF trades on the electronic stock exchange.Moves Guardant Health
-
MarketBeat Mentioned togetherFreedom Capital lowered Gentex's rating, while MarketBeat reported consensus ratings for the company, which is listed on Nasdaq.Moves Guardant Health
Connections
The 35 strongest of 70, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
AmirAli Talasaz Structural
AmirAli Talasaz serves as a co-founder and co-CEO of Guardant Health.
-
Nasdaq Structural
Guardant Health is a publicly traded company listed on the Nasdaq stock exchange.
-
FDA Structural
The FDA formally regulates and grants designations and approvals to Guardant Health's diagnostic tests.
-
Helmy Eltoukhy Structural
Helmy Eltoukhy holds critical executive leadership roles (Chairman, CEO) at Guardant Health, making him a core component of the company's structure.
-
American Cancer Society Structural
one depends on the other
-
SEC Structural
Guardant Health operates under the regulatory oversight and mandatory disclosure requirements of the SEC.
-
Meaghan Smith Structural
Meaghan Smith serves as the media contact for Guardant Health.
-
Securities and Exchange Commission Structural
Guardant Health operates under the regulatory oversight of the U.S. Securities and Exchange Commission, including specific filing requirements.
Show all 35 connections
-
Medicare Structural
Guardant Health must align its coverage terms with the established standards of the Medicare program to gain market access.
-
Manuel Hidalgo Structural
Manuel Hidalgo serves as a director of Guardant Health, establishing a formal governance link.
-
SPDR Structural
SPDR holds Guardant Health stock as part of its fund portfolio.
-
National Comprehensive Cancer Network Structural
NCCN formally included Guardant Health's Shield test in its colorectal cancer screening guidelines.
-
Natera Operational
The two companies are engaged in active competition regarding cancer diagnostics, specifically concerning product claims and market disputes.
-
Mizuho Securities Operational
Mizuho Securities provides financial analysis and price targets for Guardant Health stock.
-
CCM Operational
Both companies are active healthcare peers engaged in market competition for investment and market share.
-
David Gardner Mentioned together
David Gardner has repeatedly provided stock recommendations for Guardant Health.
-
RadNet Operational
Both companies operate in the testing and diagnostics services market and are direct competitors.
-
Amplifon Operational
The two companies are noted in a comparative market analysis as competitors within the healthcare sector.
-
Chris Freeman Transactional
Insider sold company shares during the reporting period.
-
Leerink partners Transactional
Leerink partners issued a price objective rating on Guardant Health.
-
Apollo Hospitals Transactional
Apollo Hospitals launched a test utilizing technology developed by Guardant Health.
-
Chicago Shared context
Guardant Health presented clinical data at the ASCO Annual Meeting, which was held in Chicago.
-
Mizuho Mentioned together
Mizuho raised its price target for Guardant Health, indicating market assessment of Guardant Health.
-
Palo Alto Shared context
Guardant Health operates from its headquarters located in Palo Alto.
-
Agilent Technologies Operational
The two companies are identified as competitors operating within the life sciences sector.
-
Nvidia Mentioned together
The two companies are co-mentioned as high-growth stocks within investment contexts and growth ETFs.
-
MarketBeat Mentioned together
MarketBeat reports consensus ratings and financial analysis for Guardant Health.
-
GRAIL Operational
Both GRAIL and Guardant Health actively compete in the market by selling blood tests for cancer detection.
-
Manuel Hidalgo Transactional
A director sold company shares in a specific, one-time transaction.
-
Abu Dhabi Shared context
Guardant Health operates within the market context of Abu Dhabi, holding large contracts there.
-
Wisconsin Shared context
Guardant Health is expanding access to its blood test services within the state of Wisconsin.
-
Royal Bank of Canada Mentioned together
Royal Bank of Canada provides market coverage and research on Guardant Health stock.
-
EVANS Transactional
EVANS welcomed Guardant Health as a sponsor in a current agreement.
-
investing.com Mentioned together
Investing.com reports stock news related to Guardant Health.
-
Gordon railway station Shared context
No direct coupling or relationship between Guardant Health and Gordon railway station was observed in the provided evidence.
History
Events by the month they beganOctober 2026
2 eventsSeptember 2026
4 events- EVANS welcomed Guardant Health as a sponsor for a coalition planning events across North America.
- Guardant Health is listed on the electronic stock exchange (Nasdaq) and is targeting reimbursement from federal programs (Medicare).
- Insider Chris Freeman sold shares of Guardant Health during the reporting period, leading to an SEC filing on September 14, 2026.
- Comparative market analysis of two healthcare companies, Amplifon and Guardant Health, began on September 1, 2026.
August 2026
5 events- David Gardner recommended Guardant Health stock multiple times on August 31, 2026.
- Nvidia and Guardant Health are noted as dominant tech names in growth ETFs, driven by AI and cloud spending.
- Mizuho Securities lifted its price target and disclosed a transaction involving Guardant Health in an SEC filing.
- The company Guardant Health, which has a director, is based in Palo Alto.
- Guardant Health CEO sold company shares in a disclosed transaction after filing disclosures with the SEC, trading on Nasdaq.
Show 2 earlier months
June 2026
25 events- Scott Bessent's call for a rate cut fuels a risk-on environment for companies like agilon health.
- Several companies, including Guardant Health and Myriad Genetics, are competing in the liquid biopsy market.
- Guardant Health reported results from Palo Alto on July 31, 2025. Shield MCD received Breakthrough Device Designation from the FDA and was included in NCCN colorectal cancer screening guidelines.
- Guardant Health shares are traded on Nasdaq, Mizuho raised its price target, and FDA approval spurred a positive market reaction.
- SPDR fund announced it holds shares of Molina Healthcare, BrightSpring Health Services, and Guardant Health.
- Agilent Technologies and Guardant Health are in the life sciences sector, and analyst coverage was initiated on Agilent's shares.
- Guardant Health traded on the NASDAQ stock exchange on June 23, 2026.
- Guardant Health expands access to its blood test in Wisconsin.
- Director Ian T Clark sold shares in Guardant Health on June 21, 2025.
- Insider AmirAli Talasaz sold shares worth $5,087,630 at Guardant Health on July 3, 2025.
- Strategic partnership integrates Guardant Health's portfolio into the VieCure platform, with Michael Power as CEO of VieCure Inc.
- Guardant Health announced on July 15, 2025, that its test was being used in the NCI's Vanguard Study, with data presented at ASCO in Chicago and FDA review initiated for IDE.
- Meaghan Smith serves as the media contact for Guardant Health.
- Guardant Health and Zebra Technologies provide specialized industrial equipment amidst market volatility influenced by political events.
- Guardant Health announced a partnership on July 30, 2025, aimed at raising awareness about Colorectal Cancer (CRC) screening.
- Zacks Investment Research published stock analysis reports concerning Guardant Health on July 31, 2025.
- Guardant Health used LinkedIn for company communication and had a representative participate in a conference held in Boston.
- Guardant Health develops blood tests for cancer detection, and Compass operates as a residential real estate brokerage.
- Guardant Health announced AmirAli Talasaz as Co-CEO, alongside reports of volume growth and gross margin turnaround.
- Rate cut speculation is noted to benefit growth sectors, including healthcare companies like Guardant Health.
- Guardant Health is governed by Nasdaq Listing Rule 5635(c)(4) regarding stock grants.
- Guardant Health develops blood tests for cancer detection, LGI Homes specializes in US home construction, and Maximus provides government services.
- Guardant Health participated in a conference hosted by Morgan Stanley on August 27, 2025.
- Guardant Health announced it will host its Investor Day in New York City on August 29, 2025.
- Guardant Health and Natera face a lawsuit regarding disputes over cancer diagnostics and misleading advertising claims, presided over by Judge Edward Chen.